A detailed history of Accurate Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Accurate Wealth Management, LLC holds 14,052 shares of ABBV stock, worth $2.73 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
14,052
Previous 12,406 13.27%
Holding current value
$2.73 Million
Previous $2.26 Million 6.68%
% of portfolio
0.57%
Previous 0.64%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$154.79 - $180.76 $254,784 - $297,530
1,646 Added 13.27%
14,052 $2.41 Million
Q1 2024

Apr 22, 2024

BUY
$159.82 - $182.1 $189,866 - $216,334
1,188 Added 10.59%
12,406 $2.26 Million
Q4 2023

Jan 12, 2024

SELL
$137.6 - $154.97 $59,856 - $67,411
-435 Reduced 3.73%
11,218 $1.74 Million
Q3 2023

Oct 23, 2023

BUY
$133.59 - $154.65 $54,905 - $63,561
411 Added 3.66%
11,653 $1.74 Million
Q2 2023

Jul 24, 2023

BUY
$132.51 - $164.9 $101,502 - $126,313
766 Added 7.31%
11,242 $1.51 Million
Q1 2023

Apr 13, 2023

BUY
$144.61 - $166.54 $491,240 - $565,736
3,397 Added 47.99%
10,476 $1.67 Million
Q4 2022

Jan 11, 2023

SELL
$138.31 - $165.87 $3.15 Million - $3.78 Million
-22,765 Reduced 76.28%
7,079 $0
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $3.21 Million - $3.68 Million
23,904 Added 402.42%
29,844 $4.3 Million
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $1.27 Million - $1.61 Million
-9,195 Reduced 60.75%
5,940 $906,000
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $1.1 Million - $1.36 Million
8,327 Added 122.31%
15,135 $2.45 Million
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $6,660 - $8,427
62 Added 0.92%
6,808 $813,000
Q3 2021

Oct 22, 2021

BUY
$106.4 - $120.78 $61,180 - $69,448
575 Added 9.32%
6,746 $731,000
Q2 2021

Aug 25, 2021

BUY
$105.21 - $117.21 $649,250 - $723,302
6,171 New
6,171 $695,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Accurate Wealth Management, LLC Portfolio

Follow Accurate Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accurate Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Accurate Wealth Management, LLC with notifications on news.